KPC Pharmaceuticals (600422.SS) Earnings Analysis

KPC Pharmaceuticals (600422.SS) next reports earnings on 2026-08-22. Trailing P/E 61.02.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 600422.SS next report earnings?

Next earnings date2026-08-22
Consensus EPS estimaten/a
Revenue estimaten/a

600422.SS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-25-0.19 CNYn/an/an/a
2026-02-060.1 CNYn/an/an/a
2025-10-240.09381 CNYn/an/an/a
2025-04-280.12 CNYn/an/an/a
2025-02-100.3459 CNYn/an/an/a
2024-10-250.2086 CNYn/an/an/a
2024-08-220.1463 CNYn/an/an/a

600422.SS valuation and analyst view

Trailing P/E61.02
Trailing EPS0.15545 CNY
Price / book1.32
Dividend yield3.30%
Market cap6.74B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is KPC Pharmaceuticals (600422.SS)'s next earnings date?

KPC Pharmaceuticals is next scheduled to report on 2026-08-22.

Did 600422.SS beat earnings last quarter?

Consensus estimate data was not available for 600422.SS's 2026-04-25 report.

What is 600422.SS's current P/E ratio and EPS?

600422.SS trades at a trailing P/E of 61.02 on trailing EPS of 0.15545356890471726 CNY.

What do analysts rate 600422.SS?

600422.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.